pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CURIUM · news · pharmadog
← back to CURIUM
News mentioning CURIUM
11
stories
23d
Curium prices generic radioligand at 5% discount to Novartis' Lutathera
endpoints
Sep 29, 26
3 steps for taking on Novartis in radiopharma: Curium up first
biospace
Sep 24, 26
How radioligand therapy is rewriting cancer care
biospace
Sep 15, 26
FDA clears first generic radioligand drug; Sionna turns to layoffs
biopharma dive
Sep 15, 26
FDA approves first radioligand generic, setting up rivalry with Novartis
endpoints
Aug 25, 26
Preparing for Novartis showdown, Curium touts value of radiopharma supply resiliency
biospace
Aug 17, 26
FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify
fiercebiotech
Aug 3, 26
Curium buys radiopharma rival Lantheus for $8B; Sandoz settles price-fixing case
endpoints
Aug 3, 26
Supernus and Indivior merge to create CNS mega-company with 11 approved drugs
biospace
Aug 3, 26
Curium strikes up to $8B deal for radiopharma rival Lantheus
fiercebiotech
Jun 4, 26
Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug
endpoints
